One Kern County Pharmacists main concern is on how Pharmacy Beneficiary Mangers are regulations make an impact on her family ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

UnitedHealth Group reported mixed financial results for Q4, with a rise in medical care ratio and CEO's tribute to the late ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

Amid intense criticism, UnitedHealth Group reported a $29 billion increase in 2024 revenues today, up 8% to $400.3 billion.

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...